期刊文献+

注射用头孢唑肟钠在复方氨基酸注射液中稳定性的研究 被引量:3

INVESTIGATION OF THE COMPATIBLE STABILITY CEFTIZOXIME SODIUM FOR INJECTION IN COMPOUND AMINO ACID INJECTION
下载PDF
导出
摘要 目的观察注射用头孢唑肟钠在复方氨基酸注射液(18AA)配伍后,混合液放置时间与药物稳定性的关系。方法采用高效液相色谱法测量室温下注射用头孢唑肟钠与复方氨基酸注射液配伍后,放置4 h内配伍液的性状、pH值、不溶性微粒及含量的变化。结果注射用头孢唑肟钠与复方氨基酸注射液配伍后,性状、pH值及含量无明显变化。不溶性微粒与放置时间有关。结论注射用头孢唑肟钠在复方氨基酸注射液配伍后,应在2 h内使用。 Objective To study the compatible stability of Ceftizoxime Sodium for Injection in Compound Amino Acid Injection. Methods The contents of the Ceftizoxime Sodium for Injection were determined by HPLC at different time within 4 h after mixing with Compound Amino Acid Injection. and the appearance and pH values of the mixed solutions were observed as well Results No marked changes were noted in the contents, appearance and pH assay of the Ceftizoxime Sodium for Injection mixed with Compound Amino Acid Injection. Conclusion Ceftizoxime Sodium for Injection can be used within 2 h after mixing with Compound Amino Acid Injection at room temperature.
作者 郭静 周学琴
出处 《现代医院》 2009年第9期60-61,共2页 Modern Hospitals
关键词 注射用头孢唑肟钠 复方氨基酸注射液 配伍稳定性 Ceftizoximc Sodium for Injection, Compound Amino Acid Injection, Compatible Stability
  • 相关文献

参考文献2

二级参考文献6

  • 1WS-205(X-177)-99.SFDA Drug Standard[国家药品监督管理局药品标准(试行)].[S].,..
  • 2Johnson CA, Kelloway JS, Tonelli A, et al. Single - dose pharmacokinetics of piperacillin and tazobactam in patients with renal disease.Clin Pharmacol Ther,1992,51 ( 1 ) :32.
  • 3Wise R, Logan M, Cooper M, et al. Pharmacokinetics and penetration of tazobactam administered alone and with piperacillin. Antimicrob Agents Chemother, 1992,36(6) : 1997.
  • 4.ChP(中国药典).Vol Ⅱ(二部)[M].,2000.Appendix(附录)64.
  • 5裴保香,谭次娥,孙效东,王睿,傅宏义,李玉柱.头孢哌酮的药物动力学及药效学[J].中国临床药学杂志,1998,7(5):211-214. 被引量:12
  • 6商澎,徐明达.血清和组织间液中头孢哌酮的高效液相色谱测定方法[J].药物分析杂志,1992,12(6):327-329. 被引量:9

共引文献62

同被引文献10

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部